Works matching IS 02698811 AND DT 2020 AND VI 34 AND IP 1
Results: 10
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of long-term antipsychotics treatment on body weight: A population-based cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of an adenosine A<sub>2A</sub> agonist on the rewarding associative properties of nicotine and neural plasticity in a rodent model of schizophrenia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor trafficking.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication.
- Published in:
- 2020
- By:
- Publication type:
- journal article
EMD386088 (5 mg/kg) has no effect on latent inhibition shown to both light and noise stimuli.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prebiotic supplementation does not affect reading and cognitive performance in children: A randomised placebo-controlled study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia.
- Published in:
- 2020
- By:
- Publication type:
- journal article